Literature DB >> 28864728

mTOR Pathway Mutations and Response to Rapalogs in RCC-Letter.

Juan M Roldan-Romero1, Juan F Rodríguez-Moreno2,3, Jesus García-Donás4,3, Cristina Rodríguez-Antona5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28864728     DOI： 10.1158/1078-0432.CCR-17-1280

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  1 in total

Review 1.  Mechanistic Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Potential, Limitations, and Perspectives.

Authors:  Seraina Faes; Nicolas Demartines; Olivier Dormond
Journal:  Front Cell Dev Biol       Date:  2021-03-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.